Cargando…

A Novel Link between Plasma MicroRNA-33b Levels and Lipid Disorders in Diabetes Mellitus

Detalles Bibliográficos
Autor principal:	Ono, Koh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113742/ https://www.ncbi.nlm.nih.gov/pubmed/27476669 http://dx.doi.org/10.5551/jat.ED056

Ejemplares similares

Serum microRNA Levels in Diabetes Mellitus
por: Mastropasqua, Rodolfo, et al.
Publicado: (2021)

Delivery of microRNA-33 Antagomirs by Mesoporous Silica Nanoparticles to Ameliorate Lipid Metabolic Disorders
por: Tao, Yaoye, et al.
Publicado: (2020)

First Trimester Plasma MicroRNA Levels Predict Risk of Developing Gestational Diabetes Mellitus
por: Légaré, Cécilia, et al.
Publicado: (2022)

Clinical Significance of Determining Plasma MicroRNA33b in Type 2 Diabetic Patients with Dyslipidemia
por: Kimura, Yuki, et al.
Publicado: (2016)

Aberrant expression of plasma microRNA-33a in an atherosclerosis-risk group
por: Kim, Soo Hwan, et al.
Publicado: (2016)

MicroRNA, Insulin Resistance, and Metabolic Disorders
por: Lee, Wan
Publicado: (2022)

Increased MicroRNA-146a Levels in Plasma of Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Rong, Ying, et al.
Publicado: (2013)

The Potential Role of MicroRNA in Diabetic Cardiomyopathy
por: Kim, Jin Hwa
Publicado: (2020)

MicroRNA, Diabetes Mellitus and Colorectal Cancer
por: Wang, Hsiuying
Publicado: (2020)

MicroRNA-33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE(−/−) Mice
por: Horie, Takahiro, et al.
Publicado: (2012)

Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis
por: Miyagawa, Sawa, et al.
Publicado: (2023)

The potential for microRNA-based therapeutics in retinal disorders
por: Chu-Tan, Joshua A., et al.
Publicado: (2020)

MicroRNA-24 and the Diabetic Heart
por: Rienks, Marieke, et al.
Publicado: (2018)

MicroRNA-34a and vascular senescence in diabetes
por: Thounaojam, Menaka C., et al.
Publicado: (2019)

Identification of Differential Roles of MicroRNA‐33a and ‐33b During Atherosclerosis Progression With Genetically Modified Mice
por: Koyama, Satoshi, et al.
Publicado: (2019)

microRNA Bioinformatics
por: Taguchi, Y-h.
Publicado: (2022)

Trimetazidine Increases Plasma MicroRNA-24 and MicroRNA-126 Levels and Improves Dyslipidemia, Inflammation and Hypotension in Diabetic Rats
por: Ramezani-Aliakbari, Fatemeh, et al.
Publicado: (2020)

Role of microRNA-33a in malignant cells
por: Gao, Chang, et al.
Publicado: (2020)

Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis?
por: Sidorkiewicz, Malgorzata
Publicado: (2023)

Circulating and Exosomal microRNA-33 in Childhood Obesity
por: Cabiati, Manuela, et al.
Publicado: (2023)

Epigenetic and microRNA-mediated regulation in diabetes
por: Muhonen, Pirkko, et al.
Publicado: (2009)

MicroRNA-33a-5p sponges to inhibit pancreatic β-cell function in gestational diabetes mellitus LncRNA DANCR
por: Feng, Yan, et al.
Publicado: (2020)

MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice
por: Horie, Takahiro, et al.
Publicado: (2013)

MicroRNA Sequences Modulated by Beta Cell Lipid Metabolism: Implications for Type 2 Diabetes Mellitus
por: Tarlton, Jamie M. R., et al.
Publicado: (2021)

microRNA-33 maintains adaptive thermogenesis via enhanced sympathetic nerve activity
por: Horie, Takahiro, et al.
Publicado: (2021)

MicroRNA and Cardiovascular Disease
por: Liao, Xiao-Bo, et al.
Publicado: (2015)

MicroRNA-in drug resistance
por: Li, Haoran, et al.
Publicado: (2014)

microRNA biogenesis and senescence
por: Gómez-Cabello, Daniel, et al.
Publicado: (2013)

Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma
por: Fang, Zanxi, et al.
Publicado: (2015)

Relationships between plasma expression levels of microRNA-146a and microRNA-132 in epileptic patients and their cognitive, mental and psychological disorders
por: Huang, Hui, et al.
Publicado: (2021)

Podocytes and microRNA-30/Cx43 axis in diabetic nephropathy
por: Kim, Seo Rin, et al.
Publicado: (2021)

MicroRNA-33 suppresses CCL2 expression in chondrocytes
por: Wei, Meng, et al.
Publicado: (2016)

Sex Differences in Plasma MicroRNA Biomarkers of Early and Complicated Diabetes Mellitus in Israeli Arab and Jewish Patients
por: Meerson, Ari, et al.
Publicado: (2019)

Plasma MicroRNA Levels Following Resection of Metastatic Melanoma
por: Latchana, Nicholas, et al.
Publicado: (2017)

MicroRNA and Renal Allograft Monitoring
por: Zununi, Sepide, et al.
Publicado: (2013)

MicroRNA Regulation of Oxidative Stress
por: Banerjee, Jaideep, et al.
Publicado: (2017)

microRNA-based biomarker for dementia
por: Toyama, Kensuke, et al.
Publicado: (2019)

MicroRNA and Cardiovascular Disease 2016
por: Yuan, Ling-Qing, et al.
Publicado: (2017)

microRNA Biomarkers in Clinical Study
por: Wang, Hsiuying, et al.
Publicado: (2021)

MicroRNA 33 Regulates the Population of Peripheral Inflammatory Ly6C(high) Monocytes through Dual Pathways
por: Baba, Osamu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9nt6qcl6o6i4b2p9dvjahidg6f